Doctaly (BDM Medical Ltd) has developed Doctaly Assist remote monitoring technology and this is the focus for the company.
Doctaly began life as the private GP company Doctaly and in 2018 claimed to be the UK’s first online GP marketplace that enabled patients to book a convenient face-to-face consultation with an NHS GP on a private, fee-paying basis.
Strategy
In 2025, Doctaly appears to be a company totally focused on its remote monitoring system, Doctaly Assist, a highly flexible remote patient monitoring platform developed in collaboration with the NHS, patient groups and leading UK academic institutions. According to the company website, the technology covers over two million patients in South East London with a range of long term conditions.
The company is a subsidiary of US company SOAP Health, a company developing a medical AI assistant.
The company's early development involved a private GP service. By 2018, Doctaly has already been introduced in Manchester, the West Midlands, Kent, Surrey and Scotland. The company noted that it plans to expand to 10,000 NHS GP practices nationally, this has not happened, however.
Doctaly is the trading name of BDM Medical Ltd. The company was incorporated on 11 November 2014, founded by entrepreneurs Ben Teichman and GP Dr Dinesh Silva.
Financials
BDM Medical trades as Doctaly and files abbreviated accounts on Companies House. The most recent documents filed list shareholders funds as of June 2024 as £1,039,164. In this period it had three employees.
Following a successful pilot launch in 2016, the company launched a Crowdcube funding campaign aiming to raise £500,000. As of June 2018, they had reached over £807,000.
The business has also been funded by director’s loans from the Founder and SEIS/EIS investment* from external investors.
* SEIS/EIS are schemes that to encourage seed investment into early-stage, high risk, small companies by offering tax breaks on new shares in those companies.
Investors
In February 2025 Soap Health Ltd became a person with significant control according to Companies House filings, holding between 25-50% of the company. Soap Health Ltd is a company developing a medical AI assistant.
Previously, in November 2023, Unity Health Group became a person with significant control according to Companies House filings, holding between 25-50% of the company.
Doctaly received over £807k funding on Crowdcube from 1,134 investors at an equity of 11.86% and a pre-money valuation of £6,000,000. According to Crunchbase the company had a second round of equity crowdfunding in December 2019 which raised £63.5K.
The company said investors both large and small can access an early-stage investment opportunity, with a minimum investment of £10 “in one of the fastest growing tech markets globally”.
Contracts
Doctaly's technology is ChatDoc (previously Doctaly Assist) based on WhatsApp. The website notes that no app or login is required, patients simply send a WhatsApp message to their practice phone number.
The website states that the "Chatbot allows patients to respond to questions in their own time, initially safety-netting and signposting in the event of any red-flag symptoms, placing each request into the relevant group, to be picked up and dealt with by the appropriate team."
Doctaly Assist is also a remote Patient Monitoring platform, built with guidance from King’s College, King’s Health Partners, Imperial College, Oxford University and South East London CCG.
Doctaly Assist's chatbot functionality is bespoke to the NHS and provides NHS clinicians with a tool to easily and efficiently support their patients with a wide variety of Long Term Conditions (LTCs), including asthma, diabetes, hypertension, COPD and Mental Health problems. The company also provided a Covid-19 specific version of the platform to NHS patients, as part of the UK response to Coronavirus. In February 2021, One Health in Lewisham made the Covid-19 specific Doctaly Assist plus an oximeter available to patients with the infection in the community, to enable remote monitoring by a GP.
Patients provide their symptoms and vital signs through an interface, whilst the Doctaly Assist platform enables clinicians to remotely monitor them based on urgency, ensuring that the most unwell patients are flagged, prioritised and escalated for further care in the most appropriate clinical setting.
According to the company, Doctaly Assist is now delivering Remote Patient Monitoring services to a population of circa 2.1m patients in London. The company is also an officially accredited supplier on the UK Government’s Spark Dynamic Purchasing System Framework.
In April 2018, Doctaly reported that it had signed deals with 36 UK GP practices, 35 in England and 1 in Scotland, pairing NHS GP practices with fee-paying patients. This follows a successful pilot programme of the service in London in 2016. However, the company website no longer mentions this side of the business.
